ATP10A Activators
ATP10A, a flippase enzyme, facilitates the translocation of specific lipids across cellular membranes, maintaining asymmetry in lipid distribution which is vital for cell function. Chemicals such as 4-Phenylbutyrate and its sodium salt are known chemical chaperones that can enhance the correct folding and trafficking of membrane proteins, including ATP10A. This leads to an increased presence of functionally active ATP10A at the cellular membrane, thus potentially increasing its lipid translocation activity. Phosphatidylserine, being a component of the inner leaflet of the plasma membrane, can also assist in ATP10A functionality by ensuring an optimal lipid environment for ATP10A's activity. Miltefosine and curcumin, by integrating into the lipid bilayer, can change the lipid composition and membrane fluidity, which may increase the accessibility of substrates to ATP10A and enhance its flippase activity. Glycyrrhizin's ability to stabilize glycosylation patterns could also improve ATP10A stability and functionality, while bezafibrate, a PPAR agonist, may enhance ATP10A activity indirectly by upregulating lipid metabolism and increasing substrate availability.
Further, compounds like U18666A disrupt cholesterol homeostasis, thereby possibly necessitating increased ATP10A activity to restore membrane lipid balance. Progesterone, by influencing membrane lipid organization, may create favorable conditions forATP10A Activators. Progesterone, by influencing membrane lipid organization, may create favorable conditions for ATP10A's lipid translocation processes. Anesthetics such as dibucaine and chlorpromazine interact with the lipid bilayer, potentially increasing membrane fluidity and, by extension, ATP10A activity. Lastly, nimodipine, by modulating calcium signaling, may indirectly affect ATP10A's activity, as calcium plays a role in numerous membrane-related processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium phenylbutyrate | 1716-12-7 | sc-200652 sc-200652A sc-200652B sc-200652C sc-200652D | 1 g 10 g 100 g 1 kg 10 kg | $77.00 $166.00 $622.00 $5004.00 $32783.00 | 43 | |
4-Phenylbutyrate acts as a chemical chaperone that can enhance protein folding and trafficking, thus potentially increasing the functional surface expression of ATP10A by promoting its correct localization to the plasma membrane. | ||||||
L-α-Lecithin, Egg Yolk, Highly Purified | 8002-43-5 | sc-203096 | 250 mg | $135.00 | ||
Phosphatidylserine can influence lipid bilayer composition and fluidity, which could enhance the flippase activity of ATP10A by optimizing the membrane environment for its catalytic action. | ||||||
Miltefosine | 58066-85-6 | sc-203135 | 50 mg | $81.00 | 8 | |
Miltefosine is a choline-containing phospholipid that can insert into cell membranes, altering their composition. This could indirectly enhance ATP10A activity by affecting substrate availability within the lipid bilayer. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has been shown to influence membrane fluidity and permeability. These changes can indirectly increase the activity of ATP10A by optimizing the membrane environment for its lipid translocation activity. | ||||||
Glycyrrhizic acid | 1405-86-3 | sc-279186 sc-279186A | 1 g 25 g | $57.00 $333.00 | 7 | |
Glycyrrhizin can inhibit enzyme activities that modify the glycosylation status of proteins. By stabilizing the glycosylation pattern, it may enhance the stability and function of ATP10A in the membrane. | ||||||
Bezafibrate | 41859-67-0 | sc-204650B sc-204650 sc-204650A sc-204650C | 500 mg 1 g 5 g 10 g | $31.00 $46.00 $122.00 $204.00 | 5 | |
Bezafibrate is a peroxisome proliferator-activated receptor (PPAR) agonist. Activation of PPARs can lead to upregulation of lipid metabolism genes, which may indirectly enhance ATP10A's lipid translocation activity by increasing the availability of its lipid substrates. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $143.00 $510.00 | 2 | |
U18666A is an intracellular cholesterol transport inhibitor that can disrupt cholesterol homeostasis, which may indirectly enhance ATP10A activity by increasing the need for phospholipid translocation to maintain membrane cholesterol distribution. | ||||||
Progesterone | 57-83-0 | sc-296138A sc-296138 sc-296138B | 1 g 5 g 50 g | $20.00 $52.00 $298.00 | 3 | |
Progesterone interacts with membrane-bound receptors and can influence membrane lipid organization. This interaction may enhance ATP10A activity by altering the membrane environment in a way that favors its lipid translocation process. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine can intercalate into the lipid bilayer, affecting lipid packing and membrane fluidity. These alterations may indirectly enhance the activity of ATP10A by optimizing the membrane properties for lipid transport. | ||||||
Nimodipine | 66085-59-4 | sc-201464 sc-201464A | 100 mg 1 g | $61.00 $307.00 | 2 | |
Nimodipine is a calcium channel blocker that can influence intracellular calcium levels. By modulating calcium signaling, it may affect the phospholipid transport activity of ATP10A indirectly, as calcium can be a cofactor in various lipid transport processes. | ||||||